- Telehealth Visits
- Insurance plan information
Michelle E. Guy, MD
Internal Medicine • Obesity Medicine- Telehealth Visits
- Insurance plan information
Michelle E. Guy, MD
Internal Medicine • Obesity Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Michelle Guy is a specialist in internal medicine and obesity medicine. She provides primary care.
Guy earned her medical degree from the University of Missouri School of Medicine. She completed a residency in primary care at Cambridge Health Alliance, an affiliate of Harvard Medical School. She served as chief resident.
Guy teaches UCSF medical students and residents in the clinic setting.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, Cambridge Hospital
Internship
- Internal Medicine, Cambridge Hospital
Degree
- MD, University of Missouri at Columbia
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 47 reviews
- May 27, 20265 out of 5 Stars
Dr. Guy is a terrific doctor. I feel fortunate to be in her care.
- May 27, 20265 out of 5 Stars
Dr Guy has consistently been excellent provider. I feel she hears my concerns and addresses them immediately
- May 14, 20265 out of 5 Stars
With Dr Guy, it's definitely a two-way conversation. We talk to each, not just a one sided listening session.
- April 13, 20265 out of 5 Stars
Dr Guy is awesome!
- April 9, 20265 out of 5 Stars
Love Dr Guy
- March 25, 20265 out of 5 Stars
My doctor is the GOAT
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.